Literature DB >> 3958937

Buccal and oral bioavailability of nalbuphine in rats.

M A Hussain, B J Aungst, E Shefter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958937     DOI: 10.1002/jps.2600750226

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Perfusion cells for studying regional variation in oral-mucosal permeability in humans. I: Kinetic aspects in oral-mucosal absorption of alkylparabens.

Authors:  Y Kurosaki; K Yano; T Kimura
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 2.  Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Authors:  Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs.

Authors:  M A Hussain; B J Aungst; C A Koval; E Shefter
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

4.  Commonly used excipients modulate UDP-glucuronosyltransferase 2b7 activity to improve nalbuphine oral bioavailability in humans.

Authors:  Hong-Jaan Wang; Cheng-Huei Hsiong; Shung-Tai Ho; Min-Jen Lin; Tung-Yuan Shih; Pei-Wei Huang; Oliver Yoa-Pu Hu
Journal:  Pharm Res       Date:  2014-02-14       Impact factor: 4.200

5.  Improvement of the oral bioavailability of the selective dopamine agonist N-0437 in rats: the in vitro and in vivo activity of eight ester prodrugs.

Authors:  I den Daas; P G Tepper; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.